Topsail Wealth Management LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 1,180 shares of the healthcare conglomerate's stock, valued at approximately $597,000.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in UNH. NewSquare Capital LLC bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $25,000. Hurley Capital LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $28,000. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $30,000. Aster Capital Management DIFC Ltd bought a new position in shares of UnitedHealth Group in the 4th quarter worth about $30,000. Finally, Promus Capital LLC bought a new position in shares of UnitedHealth Group in the 4th quarter worth $32,000. Institutional investors own 87.86% of the company's stock.
Wall Street Analysts Forecast Growth
Several analysts have recently commented on UNH shares. Wells Fargo & Company lowered their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a report on Tuesday, January 28th. KeyCorp dropped their price objective on shares of UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Cantor Fitzgerald reissued an "overweight" rating and set a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Argus downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Monday, April 21st. Finally, Truist Financial lowered their price objective on shares of UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating on the stock in a research report on Monday, April 21st. Three investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and three have given a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $603.05.
Get Our Latest Stock Analysis on UnitedHealth Group
UnitedHealth Group Trading Down 1.4 %
UnitedHealth Group stock traded down $6.05 during mid-day trading on Friday, reaching $418.20. 9,255,934 shares of the company traded hands, compared to its average volume of 4,482,211. The firm has a market capitalization of $380.66 billion, a price-to-earnings ratio of 26.98, a P/E/G ratio of 1.37 and a beta of 0.61. The firm's 50 day moving average price is $503.28 and its 200 day moving average price is $534.62. UnitedHealth Group Incorporated has a 52-week low of $412.02 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the previous year, the business earned $6.91 earnings per share. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 2.01%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is 35.18%.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.